UP!

PATH $13.25

PATH target price
13.25
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

5132-03-31
2014-01-22 Downgrade Wedbush Outperform to Neutral
2013-12-16 Downgrade Stifel Nicolaus Buy to Hold
2013-11-15 Reiterated Rating Needham & Company LLC Hold
1970-01-01
5132-03-31
2014-01-22 Downgrade Wedbush Outperform to Neutral
2013-12-16 Downgrade Stifel Nicolaus Buy to Hold
2013-11-15 Reiterated Rating Needham & Company LLC Hold
1970-01-01

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
BVP GP LLC 7.77%  (2433429) PATH /
BioAdvance Ventures L P 0.86%  (268879) PATH /